Accord Synergy Limited Allots 4 Lakh Equity Shares on Preferential Basis
Accord Synergy Limited has approved the allotment of equity shares on a preferential basis, granting 400,000 shares to Dr. Faruk Patel. The decision was formalized by the Company’s Board of Directors on June 11, 2026.Under the terms of the transaction, the Equity Shares were allotted for cash consideration at an issue price of ₹ 42.35 per share. Each equity share carries a face value of Rs. 10.
The allotment further updated the issued and subscribed capital structure of Accord Synergy Limited. The company's total paid-up capital increased following the transaction, which included the issuance of the new shares.
Key details regarding the change in capital are presented below:
| Particulars | Before Allotment (Shares) | Before Allotment (Value) | After Allotment (Shares) | After Allotment (Value) |
|---|---|---|---|---|
| Equity Share Capital | 34,72,000 | Rs. 3,47,20,000 | 38,72,000 | Rs. 3,87,20,000 |
| Subscribed and Paid-up Capital | 34,72,000 | Rs. 3,47,20,000 | 38,72,000 | Rs. 3,87,20,000 |
The shares allotted on a preferential basis will rank pari passu with the existing equity shares of Accord Synergy Limited.
ACCORD Stock Price Movement
Today, Accord Synergy Limited shares rallied strongly, closing the day at ₹82 after gaining 4.99%, with the stock price marking a momentous high as it hit its 52-week peak. The rally was supported by solid trading activity, registering 4,000 shares traded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.